New peptide drugs could take aim at a broader range of proteins that cause certain cancers, viral infections, and brain ...

New recommendations suggest holding back on SGLT2 inhibitors and GLP-1s among those at a lower risk for cardiovascular or ...

The brain’s map of the body remains largely unaffected by amputation, potentially informing phantom limb pain management and ...

In nine studies (76 patients), the anti-IgE monoclonal antibody omalizumab (Xolair), given every 2-4 weeks at doses ranging ...

A UK study shows that ADHD in young women increased during the COVID-19 pandemic, peaking in the age group 20-24 years; ...

About 23% of MRI scans of the hand or wrist may reveal an incidental finding, and only about 3% overall may need further ...

Despite more treatment options Americans with irritable bowel syndrome still experience symptoms that interfere with their ...

Patients with type 2 diabetes and atopic dermatitis show higher risk for cardiovascular events, but GLP-1 agonists reduce the ...

Early initiation of recombinant growth hormone therapy, particularly before the age of 4 years, can benefit prepubertal ...

A phase 3 trial suggests reducing the use of cisplatin when treating nasopharyngeal carcinoma with toripalimab-based ...

Children with IBD and concomitant primary sclerosing cholangitis have substantially worse outcomes, with elevated risks for ...

A deep-learning analysis of three-dimensional optical coherence tomography scans shows promising accuracy in distinguishing ...